Centrosomal BRCA2 is a target protein of membrane type-1 matrix metalloproteinase (MT1-MMP)

Biochemical and Biophysical Research Communications

Volumn 443, Issue 4, 2014, Pages 1148-1154

  Wali, Nadila ^a,d   Hosokawa, Kana ^a   Malik, Sadiya ^a   Saito, Hiroko ^b   Miyaguchi, Ken ^a   Imajoh Ohmi, Shinobu ^c   Miki, Yoshio ^a,b   Nakanishi, Akira ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CANCER INSTITUTE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Friendship Hospital of Urumqi   (China)

Author keywords

BRCA2; Centrosome; MT1 MMP

Indexed keywords

BRCA2; CENTROSOME; MT1-MMP;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BINDING SITES; BRCA2 PROTEIN; CELL CYCLE; CELL DIVISION; CENTROSOME; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; MATRIX METALLOPROTEINASE 14; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; RECOMBINANT FUSION PROTEINS;

EID: 84893762267     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.12.103     Document Type: Article

References (17)

1. Breast Cancer Linkage Consortium Cancer risks in BRCA2 mutation carriers J. Natl. Cancer Inst. 91 1999 1310 1316
2. M. Goggins, M. Schutte, J. Lu, C.A. Moskaluk, C.L. Weinstein, G.M. Petersen, C.J. Yeo, C.E. Jackson, H.T. Lynch, R.H. Hruban, and S.E. Kern Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas Cancer Res. 56 1996 5360 5364 (Pubitemid 27011364)
3. S.C. Wang, R. Shao, A.Y. Pao, S. Zhang, M.C. Hung, and L.K. Su Inhibition of cancer cell growth by BRCA2 Cancer Res. 62 2002 1311 1314 (Pubitemid 34407784)
4. A. Nakanishi, X. Han, H. Saito, K. Taguchi, Y. Ohta, S. Imajoh-Ohmi, and Y. Miki Interference with BRCA2, which localizes to the centrosome during S and early M phase, leads to abnormal nuclear division Biochem. Biophys. Res. Commun. 355 2007 34 40 (Pubitemid 46273362)
5. M.J. Daniels, Y. Wang, M. Lee, and A.R. Venkitaraman Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2 Science 306 2004 876 879 (Pubitemid 39446997)
6. L.K. Su, S.C. Wang, Y. Qi, W. Luo, M.C. Hung, and S.H. Lin Characterization of BRCA2: temperature sensitivity of detection and cell-cycle regulated expression Oncogene 17 1998 2377 2381 (Pubitemid 28515391)
7. A.C. Carrano, E. Eytan, A. Hershko, and M. Pagano SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 Nat. Cell Biol. 1 1999 193 199 (Pubitemid 129500937)
8. L. Moro, A.A. Arbini, E. Marra, and M. Greco Up-regulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation J. Biol. Chem. 281 2006 22100 22107 (Pubitemid 44181914)
9. S. Zucker, D. Pei, J. Cao, and C. Lopez-Otin Membrane type-matrix metalloproteinases (MT-MMP) Curr. Top. Dev. Biol. 54 2003 1 74 (Pubitemid 137639464)
10. V.S. Golubkov, S. Boyd, A.Y. Savinov, A.V. Chekanov, A.L. Osterman, A. Remacle, D.V. Rozanov, S.J. Doxsey, and A.Y. Strongin Membrane type-1 matrix metalloproteinase (MT1-MMP) exhibits an important intracellular cleavage function and causes chromosome instability J. Biol. Chem. 280 2005 25079 25086 (Pubitemid 40934599)
11. V.S. Golubkov, A.V. Chekanov, S.J. Doxsey, and A.Y. Strongin Centrosomal pericentrin is a direct cleavage target of membrane type-1 matrix metalloproteinase in humans but not in mice: potential implications for tumorigenesis J. Biol. Chem. 280 2005 42237 42241 (Pubitemid 43023194)
12. N.D. Rawlings A large and accurate collection of peptidase cleavages in the MEROPS database Database (Oxford) 2009 2009 bap015
13. N.D. Rawlings, A.J. Barrett, and A. Bateman MEROPS: the database of proteolytic enzymes, their substrates and inhibitors Nucleic Acids Res. 40 2012 D343 50
14. K. Sakata, K. Shigemasa, N. Nagai, and K. Ohama Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary Int. J. Oncol. 17 2000 673 681
15. J.L. Jones, P. Glynn, and R.A. Walker Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas J. Pathol. 189 1999 161 168 (Pubitemid 29448907)
16. S.J. Kridel, H. Sawai, B.I. Ratnikov, E.I. Chen, W. Li, A. Godzik, A.Y. Strongin, and J.W. Smith A unique substrate binding mode discriminates membrane type-1 matrix metalloproteinase from other matrix metalloproteinases J. Biol. Chem. 277 2002 23788 23793 (Pubitemid 34952221)
17. Y.C. Ip, S.T. Cheung, and S.T. Fan Atypical localization of membrane type 1-matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma Mol. Carcinog. 46 2007 225 230 (Pubitemid 46399521)